康华生物：冻干人用狂犬病疫苗暂无境外销售

Core Viewpoint - The company emphasizes the importance of internationalizing its vaccine business and is actively pursuing strategies for market entry in the global vaccine market [1] Group 1: Internationalization Strategy - The company is closely monitoring international vaccine market access standards [1] - The company is committed to implementing an overseas expansion strategy [1] Group 2: Product Sales and Market Conditions - Currently, the company's freeze-dried human rabies vaccine (human diploid cells) has no sales outside of the domestic market [1] - Future sales strategies will be developed based on market conditions and product capacity [1]